AURA
USDAura Biosciences Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$7.090
Kõrge
$7.120
Madal
$6.615
Maht
0.28M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
411.1M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.30M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
HC Wainwright & Co. Assumes Aura Biosciences at Buy, Announces Price Target of $22
HC Wainwright & Co. analyst Andres Maldonado assumes Aura Biosciences with a Buy rating and announces Price Target of $22.
JMP Securities Reiterates Market Outperform on Aura Biosciences, Maintains $19 Price Target
JMP Securities analyst Jonathan Wolleben reiterates Aura Biosciences with a Market Outperform and maintains $19 price target.
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today
Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants
BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today
Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights
First Patient Enrolled in Multi-Dose Phase 1b/2 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer (NMIBC); Initial Data at 3 Months Expected by Year-End 2025 Strengthened Leadership Team with the Appointment of
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.